ArticleMarine biotechnology (New York, N.Y.)2026
Insulin-like Growth Factor 2 Regulates Skeletal Muscle Development in Spotted Sea Bass (Lateolabrax maculatus).
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Insulin-like growth factor 2 (IGF2) is a conserved member of the insulin superfamily, playing essential roles in growth and skeletal muscle development in vertebrates. However, its molecular functions in marine teleosts remain largely unexplored. In this study, we cloned and characterized the igf2 gene from the spotted sea bass (Lateolabrax maculatus), a commercially important aquaculture species. Bioinformatic analysis revealed that the IGF2 protein contains conserved structural domains and forms a phylogenetically clade with teleost IGF2b sequences. Tissue expression profiling and in situ hybridization confirmed strong hepatic expression of igf2, with localized cytoplasmic signals in hepatocytes. In skeletal muscle, expression analyses further indicated differential expression patterns among IGF receptors, with igf1ra transcripts prominently localized to the subsarcolemmal region of muscle fibers. To assess its function, recombinant IGF2 (rIGF2) was expressed and purified in Escherichia coli. Functional assays demonstrated that rIGF2 significantly enhanced myoblast proliferation in a dose-dependent manner, as evidenced by EdU incorporation and CCK-8 assays. Furthermore, rIGF2 promoted myotube formation and upregulated the expression of myogenic regulatory factors (myod, myog) and mitochondrial dynamics-related genes (mfn1b, mfn2, opa1, and fis1), suggesting a role in both differentiation and mitochondrial remodeling. Collectively, these findings provide new insights into IGF2 function in teleost skeletal muscle development and offer a molecular basis for future studies on growth regulation and selective breeding in marine aquaculture species.
Indexed as
Identifiers
41739243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.